Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.14

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.14). Revenue for the quarter came in at $10.44 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• ConectivGlobal launches ConeqtX and MyLife Wellness platforms
• The Canadian Chrome Company Announces Update on the Process for Sale of the Company or Its Assets and Results of Annual and Special Shareholders' Meeting